| Q35783146 | A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells |
| Q46290971 | A novel Phex mutation in a new mouse model of hypophosphatemic rickets |
| Q36303697 | Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia |
| Q46285814 | Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development |
| Q28579664 | Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3 |
| Q35932724 | Dspp-independent Effects of Transgenic Trps1 Overexpression on Dentin Formation |
| Q34283390 | Dual role of the Trps1 transcription factor in dentin mineralization. |
| Q36554782 | Emerging role of a phosphatonin in mineral homeostasis and its derangements. |
| Q36982323 | Endocrine functions of bone in mineral metabolism regulation. |
| Q37621495 | Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice |
| Q37991256 | Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis. |
| Q33992512 | Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice |
| Q27002346 | Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia |
| Q36639867 | FGF23 production by osteocytes |
| Q28177435 | FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization |
| Q36756061 | Fibroblast growth factor 23 and bone mineralisation |
| Q41907618 | Functional heterogeneity of osteocytes in FGF23 production: the possible involvement of DMP1 as a direct negative regulator. |
| Q46287351 | Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling |
| Q33623726 | Identification of two novel mutations in the PHEX gene in Chinese patients with hypophosphatemic rickets/osteomalacia |
| Q44130801 | Inhibition of MEPE cleavage by Phex. |
| Q35218561 | Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'. |
| Q37488973 | Kidney and phosphate metabolism |
| Q87417401 | Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo |
| Q40590136 | MEPE has the properties of an osteoblastic phosphatonin and minhibin. |
| Q36439625 | Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice |
| Q39656669 | Mycobacterium leprae downregulates the expression of PHEX in Schwann cells and osteoblasts. |
| Q26853017 | Nuclear receptors in bone physiology and diseases |
| Q27022407 | Osteocytes: master orchestrators of bone |
| Q51819465 | PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. |
| Q28568733 | PTHrP(1-34)-mediated repression of the PHEX gene in osteoblastic cells involves the transcriptional repressor E4BP4 |
| Q28275381 | Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia |
| Q24635849 | The amazing osteocyte |
| Q35911345 | The wrickkened pathways of FGF23, MEPE and PHEX. |
| Q37648693 | Therapeutic management of hypophosphatemic rickets from infancy to adulthood. |
| Q37980555 | Tooth dentin defects reflect genetic disorders affecting bone mineralization |
| Q35673317 | Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets |